Search

1 to 10 of 189
Sort by

Event
36th Annual Meeting & Pre-Conference Programs (SITC 2021)

The Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Registration and other details will be announced soon! Thank You to Our...

 11-10-2021 08:00 - 11-14-2021 12:00 ET
 Washington DC


Library Entry
Understanding Cancer Immunotherapy: Sixth Edition - A Patient Resource Guide

Your immune system is a powerful protection mechanism that works around the clock to defend you from harmful germs and internal stresses to normal cells in the body. After years of research, doctors have found a way to unleash its cancer-fighting potential, too. Immunotherapy harnesses the power...

2020 Immunotherapy.pdf


Library Entry
Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective

Immuno-oncologics (IOs) differ from chemotherapies as they prime the patient’s immune system to attack the tumor, rather than directly destroying cancer cells. The IO mechanism of action leads to durable responses and prolonged survival in some patients. However, providing robust evidence of the...






Library Entry
Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors

Immune checkpoint inhibitors (CIs) have revolutionized treatment of advanced melanoma, leading to an emerging population of long-term survivors. Survivors’ quality of life (QOL) and symptom burden are poorly understood. The authors evaluated symptom burden and QOL in patients with advanced...


Library Entry
Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit

Quality measures are important because they can help improve and standardize the delivery of cancer care among healthcare providers and across tumor types. In an environment characterized by a rapidly shifting immunotherapeutic landscape and lack of associated long-term outcome data, defining...


Web Page
Seattle

Saturday, Oct. 31, 2020 8:00 a.m. PDT Organizers: Shailender Bhatia, MD – University of Washington Petros Grivas, MD, PhD – University of Washington Andrea M. Perdue, PA – Seattle Cancer Care Alliance ACI Seattle Program Registration Registration for the live virtual ACI Seattle...